MegaRobo raises nearly $200 million to plug AI agents into real labs and make experiments programmable
Synopsis
MegaRobo said it raised nearly $200 million in a new round that included Oman's sovereign wealth fund, the Oman Investment Authority, with proceeds aimed at core technologies and global expansion of its AI-for-science business. The company describes its One Intelligence Stack as a reusable base that combines models and agents, data, software, scientific instruments, robotics, automation and real-world feedback, and says Megalaxy Lab lets experiments be configured, tracked and returned as machine-readable results. Megalaxy Lab has served more than 200 customers, and the company reports about $600 million raised to date.
Interpretation
MegaRobo closed a new financing round of nearly $200 million, with the Oman Investment Authority, the Sultanate of Oman's sovereign wealth fund, participating; existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures continued their support, and CMB International joined as a new investor. The company had previously raised about $600 million across several rounds, including a Series C of nearly $300 million co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia, with participation from Pavilion Capital. The company announcement names the participants and the existing-investor structure of this round, and places it against the stated cumulative total and the Series C size.
The new funding is to support further investment in core technologies, global expansion of the AI-for-science business, and infrastructure that lets AI operate in increasingly complex physical environments. The company treats science as the first proving ground for this architecture, because scientific discovery rests on a continuous cycle of reasoning, planning, physical experiments, observation and learning, often where the answer is not known in advance. The company says it has delivered products and technologies to more than 500 customers, including leading global pharmaceutical companies, drug discovery organizations, biotech companies and research institutions, covering stages from early research and target and mechanism discovery to compound screening and candidate optimization.
Megalaxy Lab makes real-world experiments increasingly programmable: researchers and AI agents can configure experiments, route them to automated lab systems, track execution, and receive structured, machine-readable results that feed directly into the next cycle of scientific reasoning. The company is extending that capability to the global AI-for-science community through Poreva Open, a protein design challenge launched with industry partners including Tencent Cloud and Twist Bioscience. Megalaxy Lab has already served more than 200 customers; Poreva Open is open to all models and technical approaches, and Megalaxy Lab will run wet-lab validation for more than 10,000 protein design sequences so innovators worldwide can test models against real experimental results.
Perspective
The report covers the financing structure, use of proceeds, the described composition of One Intelligence Stack, the more than 500 customers and more than 200 Megalaxy Lab customers, and the open scope and planned sequence count of Poreva Open, all as stated in the company announcement; the announcement gives no experimental results for these systems on specific scientific tasks.
The announcement describes architecture capability and customer reach in the company's own terms and discloses no performance metrics for the systems; the Poreva Open wet-lab validation is stated as forthcoming, with no timetable or existing results given.
